Abstract
AbstractA novel chiral metal‐organic framework (MOF) organocatalyst has been developed, based on readily available MIL‐101 and the chiral primary diamine (1R,2R)‐1,2‐diphenylethylenediamine, by the post‐synthetic modification. Over the developed chiral heterogeneous catalyst the asymmetric synthesis of (S)‐warfarin with high enantioselectivity can be fulfilled on a gram‐scale (2.8 g) with excellent yield (92%) at low cost, making the synthesis method an ideal alternative to existing methods.magnified image
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
